It was reported that the procedure was to treat a lesion located a the left circumflex artery that was heavily calcified and moderately tortuous.After soaking the nc traveler balloon system, it was advanced in the patient and air aspiration was performed.Once at the lesion, the balloon ruptured at 18 atmospheres during the first inflation.The device was removed without issue.There was no reported adverse patient effect and no clinically significant delay in the procedure.Cutting balloon angioplasty was then performed and another nc traveler balloon was used to continue the procedure, followed by deployment of a xience stent to complete procedure.No additional information was provided.
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.It was reported that the device was prepped inside the anatomy.It should be noted coronary dilatation catheters (cdc), nc traveler rx, global, (b)(4), instruction for use (ifu) specifies: all air must be removed from the balloon and displaced with contrast prior to inserting into the body, otherwise, complications may occur.In this case, it is unknown if the ifu violation caused or contributed to the reported compliant.The investigation determined the reported complaint appears to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.The nc traveler is currently not commercially available in the us; however, it is similar to a device sold in the us.
|